FemPulse was invited to present during the I3 forum sponsored by the North American Neuromodulation Society. I3, representing Innovation, Investment and Invigoration, provides a fitting context for a presentation regarding this leading edge company. The FemPulse system is a first-of- its-kind wearable neuromodulation system providing discrete, simple and continuous neuromodulation therapy for OAB. Dr. Haessler shared her vision for how “wearable” neuromodulation, such as that being developed by FemPulse, will revolutionize the field and greatly expand access for women around the world to this important therapy.
